Clinical Trial Update: Effect of Weight and/or Obesity on Sulfamethoxazole and Trimethoprim Concentrations [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the impact of weight and obesity on sulfamethoxazole/trimethoprim concentrations; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Sulfamethoxazole-trimethoprim (sulfamethoxazole-trimethoprim)

Snippet

Sponsor: Texas Tech University Health Sciences Center | Conditions: Obesity, Pharmacokinetics | Phase 4 | Status: COMPLETED | Results posted: 2016-11-02